GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-01-08 18:30 |
GENFIT informe ses actionnaires sur certaines modalités de l’Assemblée Générale…
|
French | 159.0 KB | ||
| 2021-01-08 18:30 |
GENFIT Informs its Shareholders of Certain Procedures for the Extraordinary Gen…
|
English | 110.7 KB | ||
| 2021-01-06 22:10 |
GENFIT : Participation à plusieurs événements financiers et organisation d’un K…
|
French | 139.8 KB | ||
| 2021-01-06 22:10 |
GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event
|
English | 86.5 KB | ||
| 2020-12-22 22:10 |
GENFIT: Renegotiation of the OCEANEs Convertible Bond Terms: Availability of Pr…
|
English | 640.3 KB | ||
| 2020-12-22 22:10 |
GENFIT : Renégociation des termes des OCEANEs : mise à disposition d’un prospec…
|
French | 648.6 KB | ||
| 2020-12-07 08:10 |
GENFIT annonce le succès d’une étape essentielle pour le rachat partiel et l’am…
|
French | 213.2 KB | ||
| 2020-12-07 08:10 |
GENFIT announces the successful completion of a key milestone in the partial bu…
|
English | 211.7 KB | ||
| 2020-11-30 08:10 |
GENFIT annonce être satisfaite des résultats préliminaires de l’offre de rachat…
|
French | 142.5 KB | ||
| 2020-11-30 08:10 |
GENFIT announces satisfactory preliminary results of its OCEANEs’ partial buyba…
|
English | 135.8 KB | ||
| 2020-11-23 08:15 |
GENFIT : Annonce des termes définitifs du projet de renégociation des obligatio…
|
French | 189.4 KB | ||
| 2020-11-23 08:15 |
GENFIT Announces Final Terms For Proposed Renegotiation of 2022 OCEANE Converti…
|
English | 184.7 KB | ||
| 2020-11-16 22:10 |
GENFIT : Nouvelles données présentées au Liver Meeting Digital Experience™ 2020…
|
French | 175.9 KB | ||
| 2020-11-16 22:10 |
GENFIT: New Data Presented at AASLD The Liver Meeting Digital Experience™
|
English | 193.0 KB | ||
| 2020-11-16 08:30 |
GENFIT: Third Quarter 2020 Financial Information and Launch of Renegotiation of…
|
English | 237.5 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
